T1	Participants 168 243	patients with multiple myeloma and low peripheral blood CD34(+) cell count:
T2	Participants 976 1090	patients with multiple myeloma, stratified by preapheresis PB CD34(+) cell count: <10, <15, <20, and ≥20 cells/μL.